Does protracted antiviral therapy impact on HCV-related liver cirrhosis progression?

doi:10.3748/wjg.v13.i36.4903

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 36

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1750)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

200

HTML

1271

Figures (1-2)

130

Tables (1-2)

149

Sum=1750

Sep 28, 2007 (publication date) through Apr 24, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Sep 28, 2007; 13(36): 4903-4908
Published online Sep 28, 2007. doi: 10.3748/wjg.v13.i36.4903

Full Size Figure Download Figure

Figure 2 Behaviour of Child-Pugh classification in patients on (n 35) or not on (n 36) combined antiviral therapy. Comparison of the probability curves between treated and non-treated patients was made (Log-rank test). Chi-square test = 8.3, P = 0.004; Hazard ratio = 10.9; 95% CI = 1.75-18.9.

Citation: Tarantino G, Gentile A, Capone D, Basile V, Tarantino M, Minno MNDD, Cuocolo A, Conca P. Does protracted antiviral therapy impact on HCV-related liver cirrhosis progression? World J Gastroenterol 2007; 13(36): 4903-4908
URL: https://www.wjgnet.com/1007-9327/full/v13/i36/4903.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i36.4903